完整後設資料紀錄
DC 欄位語言
dc.contributor.authorKuo, Yen-Lingen_US
dc.contributor.authorWang, Sin-Geen_US
dc.contributor.authorWu, Ching-Yien_US
dc.contributor.authorLee, Kai-Chiehen_US
dc.contributor.authorJao, Chan-Jungen_US
dc.contributor.authorChou, Shiu-Hueyen_US
dc.contributor.authorChen, Yu-Chieen_US
dc.date.accessioned2017-04-21T06:55:15Z-
dc.date.available2017-04-21T06:55:15Z-
dc.date.issued2016-10en_US
dc.identifier.issn1743-5889en_US
dc.identifier.urihttp://dx.doi.org/10.2217/nnm-2016-0232en_US
dc.identifier.urihttp://hdl.handle.net/11536/134207-
dc.description.abstractAim: Medical treatments for bacterial-infections have become challenging because of the emergence of antibiotic-resistant bacterial strains. Thus, new therapeutics and antibiotics must be developed. Materials & methods: Arginine and tryptophan can target negatively-charged bacteria and penetrate bacterial cell membrane, respectively. Synthetic-peptides containing arginine, tryptophan and cysteine termini, in other words, (DVFLG) 2 REEW 4 C and (DVFLG) 2 REEW 2 C, as starting materials were mixed with aqueous tetrachloroauric acid to generate peptide-immobilized gold nanoparticles (i.e., [DVFLG] 2 REEW 4 C-AuNPs and [DVFLG] 2 REEW 2 C-AuNPs) through one-pot reactions. Results & discussion: The peptide immobilized AuNPs exhibit targeting capacity and antibacterial activity. Furthermore, (DVFLG) 2 REEW 4 C-AuNPs immobilized with a higher number of tryptophan molecules possess more effective antibacterial capacity than (DVFLG) 2 REEW 2 C-AuNPs. Nevertheless, they are not harmful for animal cells. The feasibility of using the peptide-AuNPs to inhibit the cell growth of bacterium-infected macrophages was demonstrated. Conclusion: These results suggested that the proposed antibacterial AuNPs are effective antibacterial agents for Staphylococci, Enterococci and antibiotic-resistant bacterial strains.en_US
dc.language.isoen_USen_US
dc.subjectantibacterial peptidesen_US
dc.subjectantibioticsen_US
dc.subjectantibiotic-resistant bacteriaen_US
dc.subjectAu NPsen_US
dc.subjectEnterococcus faecalisen_US
dc.subjectEnterococcus faeciumen_US
dc.subjectmacrophagesen_US
dc.subjectMRSAen_US
dc.subjectStaphylococcus aureusen_US
dc.subjectVREen_US
dc.titleFunctional gold nanoparticle-based antibacterial agents for nosocomial and antibiotic-resistant bacteriaen_US
dc.identifier.doi10.2217/nnm-2016-0232en_US
dc.identifier.journalNANOMEDICINEen_US
dc.citation.volume11en_US
dc.citation.issue19en_US
dc.citation.spage2497en_US
dc.citation.epage2510en_US
dc.contributor.department應用化學系zh_TW
dc.contributor.departmentDepartment of Applied Chemistryen_US
dc.identifier.wosnumberWOS:000384221100003en_US
顯示於類別:期刊論文